Is FEMASYS INC (FEMY) Halal?

NASDAQ Healthcare United States $29M
✗ NOT HALAL
Confidence: 90/100
FEMASYS INC (FEMY) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 35.75% exceeds the 5% threshold allowed under AAOIFI. FEMASYS INC operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 23.6%
/ 30%
10.9%
/ 30%
1.5%
/ 30%
35.75%
/ 5%
✗ NOT HALAL
DJIM 23.6%
/ 33%
10.9%
/ 33%
1.5%
/ 33%
35.75%
/ 5%
✗ NOT HALAL
MSCI 59.8%
/ 33%
27.7%
/ 33%
3.9%
/ 33%
35.75%
/ 5%
✗ NOT HALAL
S&P 23.6%
/ 33%
10.9%
/ 33%
1.5%
/ 33%
35.75%
/ 5%
✗ NOT HALAL
FTSE 59.8%
/ 33%
27.7%
/ 33%
3.9%
/ 50%
35.75%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-0.69
P/B Ratio
5.0
EV/EBITDA
-1.8
EV: $32M
Revenue
$2M
Growth: 31.4%
Beta
-2.5
Low volatility
Current Ratio
1.2

Profitability

Gross Margin 63.1%
Operating Margin -500.9%
Net Margin 0.0%
Return on Equity (ROE) -376.2%
Return on Assets (ROA) -69.4%

Cash Flow & Balance Sheet

Operating Cash Flow-$19M
Free Cash Flow-$20M
Total Debt$7M
Debt-to-Equity185.0
Current Ratio1.2
Total Assets$12M

Price & Trading

Last Close$0.50
50-Day MA$0.55
200-Day MA$0.68
Avg Volume853K
Beta-2.5
52-Week Range
$0.31
$1.34

About FEMASYS INC (FEMY)

CEO
Ms. Kathy Lee-Sepsick M.B.A.
Employees
69
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$29M
Currency
USD

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is FEMASYS INC (FEMY) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), FEMASYS INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is FEMASYS INC's debt ratio?

FEMASYS INC's debt ratio is 23.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 59.8%.

What are FEMASYS INC's key financial metrics?

FEMASYS INC has a market capitalization of $29M, and revenue of $2M. Return on equity stands at -376.2%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.